Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Aug 19;20(35):2699–2708. doi: 10.1080/14796694.2024.2386922

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

PMC Copyright notice

Figure 1. — Description of OSE2101 (Tedopi^®) combination of epitopes. Adjuvant (Montanide ISA 51™) is entrapping all epitopes in ISE2101 in a form amenable for efficient uptake and processing/presentation by antigen presenting cells through subcutaneous route.

CEA: Carcinoembryonic Antigen; CTLA4: Cytotoxic T-lymphocyte-associated protein 4; HER2: Human Epidermal Growth Factor Receptor 2; HLA-A2: Human Leucocyte Antigen A2; P53: Protein Tumor 53; PD1:Programmed Death 1; PDL1:Programmed Death Ligand 1; MAGE-A2: Melanoma A2 Antigen; MAGE-A3: Melanoma A3 Antigen; TCR: T Cell Receptor.